References
- 1GuanYLouisEDZhengWToxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats.J Toxicol Environ Health A20016464566010.1080/15287390175324624111766171
- 2CallawayJCAiraksinenMMSalmelaKSSalaspuroMFormation of tetrahydroharman (1-methyl-1,2,3,4-tetrahydro-beta-carboline) by Helicobacter pylori in the presence of ethanol and tryptamine.Life Sci1996581817182110.1016/0024-3205(96)00165-88637407
- 3FekkesDBernardBFCappendijkSLNorharman and alcohol-dependency in male Wistar rats.Eur Neuropsychopharmacol20041436136610.1016/j.euroneuro.2003.10.00715336296
- 4BosinTRBorgSFaullKFHarman in rat brain, lung and human CSF: effect of alcohol consumption.Alcohol1988550551110.1016/0741-8329(88)90090-03245894
- 5SpijkermanRvan den EijndenRvan de MheenDBongersIFekkesDThe impact of smoking and drinking on plasma levels of norharman.Eur Neuropsychopharmacol200212617110.1016/S0924-977X(01)00143-211788242
- 6YuAMIdleJRKrauszKWKüpferAGonzalezFJContribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic β-carboline alkaloids harmaline and harmine.J Pharmacol Exp Ther200330531532210.1124/jpet.102.04705012649384
- 7MiksysSRaoYHoffmannEMashDCTyndaleRFRegional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics.J Neurochem2002821376138710.1046/j.1471-4159.2002.01069.x12354285
- 8MiksysSTyndaleRFNicotine induces brain CYP enzymes: relevance to Parkinson's disease.J Neural Transm Suppl20067017718010.1007/978-3-211-45295-0_2817017527
- 9GearhartDANeafseyEJCollinsMAPhenylethanolamine N-methyltransferase has β-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease.Neurochem Int20024061162010.1016/S0197-0186(01)00115-211900856
- 10HerraizTGuillénHGalisteoJN-methyltetrahydro-β-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic β-carbolinium cations by heme peroxidases.Biochem Biophys Res Commun200735611812310.1016/j.bbrc.2007.02.08917346675
- 11MatsubaraKGondaTSawadaHEndogenously occurring β-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease.J Neurochem19987072773510.1046/j.1471-4159.1998.70020727.x9453568
- 12HerraizTGuillénHAránVJIdleJRGonzalezFJComparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated β-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.Toxicol Appl Pharmacol200621638739810.1016/j.taap.2006.06.00316870220
- 13LouisEDBenito-LeónJBermejo-ParejaFNeurological Disorders in Central Spain (NEDICES) Study GroupPopulation-based prospective study of cigarette smoking and risk of incident essential tremor.Neurology2008701682168710.1212/01.wnl.0000311271.42596.3218458228
- 14McCannSJPondSMJamesKMLe CouteurDGThe association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis.J Neurol Sci1997153505310.1016/S0022-510X(97)00179-29455978
- 15LouisEDJiangWPellegrinoKMElevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor.Neurotoxicology20082929430010.1016/j.neuro.2007.12.00118242711
- 16LouisEDZhengWApplegateLShiLFactor-LitvakPBlood harmane concentrations and dietary protein consumption in essential tremor.Neurology20056539139610.1212/01.wnl.0000172352.88359.2d16087903
- 17ZetlerGSingbartlGSchlosserLCerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids.Pharmacology1972723724810.1159/0001362945077309
- 18LouisEDZhengWMaoXShunguDCBlood harmane is correlated with cerebellar metabolism in essential tremor: a pilot study.Neurology20076951552010.1212/01.wnl.0000266663.27398.9f17679670
- 19RibaJValleMUrbanoGYritiaMMorteABarbanojMJHuman pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.J Pharmacol Exp Ther2003306738310.1124/jpet.103.04988212660312
- 20PennesHHHochPHPsychotomimetics, clinical and theoretical considerations: harmine, Win-2299 and nalline.Am J Psychiatry195711388789213402982
- 21AhmedATaylorNRThe analysis of drug-induced tremor in mice.Br J Pharmacol Chemother19591435035413792135
- 22de MontignyCLamarreYRhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat.Brain Res197353819510.1016/0006-8993(73)90768-34697252
- 23PoirierLJSourkesTLBouvierGBoucherRCarabinSStriatal amines, experimental tremor and the effect of harmaline in the monkey.Brain196689375210.1093/brain/89.1.374956264
- 24
- 25MiwaHHamaKKajimotoYKondoTEffects of zonisamide on experimental tremors in rats.Parkinsonism Relat Disord200814333610.1016/j.parkreldis.2007.05.00817587636
- 26WangGFowlerSCConcurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine.Psychopharmacology (Berl)200115827328010.1007/s00213010088211713617
- 27de Souza da FonsecaAPereiraFRSantosRValidation of a new computerized system for recording and analysing drug-induced tremor in rats.J Pharmacol Toxicol Methods20014613714310.1016/S1056-8719(02)00169-712183189
- 28MartinFCThu LeAHandforthAHarmaline-induced tremor as a potential preclinical screening method for essential tremor medications.Mov Disord20052029830510.1002/mds.2033115580562
- 29StanfordJAFowlerSCAt low doses, harmaline increases forelimb tremor in the rat.Neurosci Lett1998241414410.1016/S0304-3940(97)00974-99502211
- 30LutesJLordenJFBealesMOltmansGATolerance to the tremorogenic effects of harmaline: evidence for altered olivo-cerebellar function.Neuropharmacology19882784985510.1016/0028-3908(88)90102-52851115
- 31LordenJFStrattonSEMaysLEOltmansGAPurkinje cell activity in rats following chronic treatment with harmaline.Neuroscience19882746547210.1016/0306-4522(88)90281-33217001
- 32StrattonSELordenJFEffect of harmaline on cells of the inferior olive in the absence of tremor: differential response of genetically dystonic and harmaline-tolerant rats.Neuroscience19914154354910.1016/0306-4522(91)90347-Q1870702
- 33O'HearnEMolliverMEDegeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline.Neuroscience19935530331010.1016/0306-4522(93)90500-F8377927
- 34MiwaHKuboTSuzukiAKihiraTKondoTA species-specific difference in the effects of harmaline on the rodent olivocerebellar system.Brain Res200610689410110.1016/j.brainres.2005.11.03616405928
- 35LlinásRYaromYElectrophysiology of mammalian inferior olivary neurones in vitro. Different types of voltage-dependent ionic conductances.J Physiol19813155495676273544
- 36LlinásRYaromYProperties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurones in vitro.J Physiol19813155695847310722
- 37LlinásRYaromYOscillatory properties of guinea-pig inferior olivary neurones and their pharmacological modulation: an in vitro study.J Physiol19863761631823795074
- 38LangEJSugiharaILlinásRDifferential roles of apamin- and charybdotoxin-sensitive K+ conductances in the generation of inferior olive rhythmicity in vivo.J Neurosci199717282528389092604
- 39PlacantonakisDGSchwarzCWelshJPSerotonin suppresses subthreshold and suprathreshold oscillatory activity of rat inferior olivary neurones in vitro.J Physiol200052483385110.1111/j.1469-7793.2000.00833.x10790162
- 40PlacantonakisDWelshJTwo distinct oscillatory states determined by the NMDA receptor in rat inferior olive.J Physiol200153412314010.1111/j.1469-7793.2001.t01-1-00123.x11432997
- 41DegenJMeierCVan Der GiessenRSExpression pattern of lacZ reporter gene representing connexin36 in transgenic mice.J Comp Neurol200447351152510.1002/cne.2008515116387
- 42LeznikEMakarenkoVLlinásRElectrotonically mediated oscillatory patterns in neuronal ensembles: an in vitro voltage-dependent dye-imaging study in the inferior olive.J Neurosci2002222804281511923445
- 43SoteloCLlinásRBakerRStructural study of inferior olivary nucleus of the cat: morphological correlates of electrotonic coupling.J Neurophysiol1974375415594827021
- 44LeznikELlinásRRole of gap junctions in synchronized neuronal oscillations in the inferior olive.J Neurophysiol2005942447245610.1152/jn.00353.200515928056
- 45De ZeeuwCIVan AlphenAMHawkinsRKRuigrokTJClimbing fibre collaterals contact neurons in the cerebellar nuclei that provide a GABAergic feedback to the inferior olive.Neuroscience19978098198610.1016/S0306-4522(97)00249-29284054
- 46SasakiKBowerJMLlinásRMultiple purkinje cell recording in rodent cerebellar cortex.Eur J Neurosci1989157258610.1111/j.1460-9568.1989.tb00364.x12106116
- 47LangEJSugiharaILlinásRGABAergic modulation of complex spike activity by the cerebellar nucleoolivary pathway in rat.J Neurophysiol1996762552758836223
- 48LangEJGABAergic and glutamatergic modulation of spontaneous and motor-cortex-evoked complex spike activity.J Neurophysiol2002871993200811929918
- 49WelshJPLangEJSuglharaILlinásRDynamic organization of motor control within the olivocerebellar system.Nature199537445345710.1038/374453a07700354
- 50Van Der GiessenRSMaxeinerSFrenchPJWilleckeKDe ZeeuwCISpatiotemporal distribution of Connexin45 in the olivocerebellar system.J Comp Neurol200649517318410.1002/cne.2087316435305
- 51LongMADeansMRPaulDLConnorsBWRhythmicity without synchrony in the electrically uncoupled inferior olive.J Neurosci200222108981090512486184
- 52PlacantonakisDGBukovskyAAZengXHKiemHPWelshJPFundamental role of inferior olive connexin 36 in muscle coherence during tremor.Proc Natl Acad Sci USA20041017164716910.1073/pnas.040032210115103021
- 53PlacantonakisDGBukovskyAAAicherSAKiemHPWelshJPContinuous electrical oscillations emerge from a coupled network: a study of the inferior olive using lentiviral knockdown of connexin36.J Neurosci2006265008501610.1523/JNEUROSCI.0146-06.200616687492
- 54MarshallSPvan der GiessenRSde ZeeuwCILangEJAltered olivocerebellar activity patterns in the connexin36 knockout mouse.Cerebellum200728113
- 55BlenkinsopTALangEJBlock of inferior olive gap junctional coupling decreases Purkinje cell complex spike synchrony and rhythmicity.J Neurosci2006261739174810.1523/JNEUROSCI.3677-05.200616467522
- 56TeuneTMvan der BurgJde ZeeuwCIVoogdJRuigrokTJSingle Purkinje cell can innervate multiple classes of projection neurons in the cerebellar nuclei of the rat: a light microscopic and ultrastructural triple-tracer study in the rat.J Comp Neurol199839216417810.1002/(SICI)1096-9861(19980309)392:2<;164::AID-CNE2>3.0.CO;2-09512267
- 57MolineuxMLMcRoryJEMcKayBESpecific T-type calcium channel isoforms are associated with distinct burst phenotypes in deep cerebellar nuclear neurons.Proc Natl Acad Sci USA20061035555556010.1073/pnas.060126110316567615
- 58UusisaariMObataKKnöpfelTMorphological and electrophysiological properties of GABAergic and non-GABAergic cells in the deep cerebellar nuclei.J Neurophysiol20079790191110.1152/jn.00974.200617093116
- 59De MontignyCLamarreYEffects produced by local applications of harmaline in the inferior olive.Can J Physiol Pharmacol19755384584910.1139/y75-1161201490
- 60BatiniCBernardJFBuisseret-DelmasCConrath-VerrierMHorcholle-BossavitGHarmaline-induced tremor. II. Unit activity correlation in the interposito-rubral and oculomotor systems of cat.Exp Brain Res19814238339110.1007/BF002375037238678
- 61LlinásRVolkindRAThe olivo-cerebellar system: functional properties as revealed by harmaline-induced tremor.Exp Brain Res197318698710.1007/BF002365574746753
- 62BatiniCBuisseret-DelmasCConrath-VerrierMHarmaline-induced tremor. I. Regional metabolic activity as revealed by [14C]2-deoxyglucose in cat.Exp Brain Res19814237138210.1007/BF002375027238677
- 63BeitzAJSaxonDHarmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway.J Neurocytol200433497410.1023/B:NEUR.0000029648.81071.2015173632
- 64ParkYGParkHYLeeCJCaV3.1 is a tremor rhythm pacemaker in the inferior olive.Proc Natl Acad Sci USA2010107107311073610.1073/pnas.100299510720498062
- 65BernardJFBuisseret-DelmasCCompointCLaplanteSHarmaline induced tremor. III. A combined simple units, horseradish peroxidase, and 2-deoxyglucose study of the olivocerebellar system in the rat.Exp Brain Res19845712813710.1007/BF002311396519221
- 66Buisseret-DelmasCSagittal organization of the olivocerebellonuclear pathway in the rat. II. Connections with the nucleus interpositus.Neurosci Res1988549451210.1016/0168-0102(88)90039-93173810
- 67FredetteBJMugnainiEThe GABAergic cerebello-olivary projection in the rat.Anat Embryol (Berl)199118422524310.1007/BF016732581793166
- 68SimantovRSnyderSHOster-GraniteMLHarmaline-induced tremor in the rat: abolition by 3-acetylpyridine destruction of cerebellar climbing fibers.Brain Res197611414415110.1016/0006-8993(76)91016-7134757
- 69LeDouxMSLordenJFAbnormal spontaneous and harmaline-stimulated Purkinje cell activity in the awake genetically dystonic rat.Exp Brain Res200214545746710.1007/s00221-002-1127-412172657
- 70LordenJFOltmansGAMcKeonTWLutesJBealesMDecreased cerebellar 3',5'-cyclic guanosine monophosphate levels and insensitivity to harmaline in the genetically dystonic rat (dt).J Neurosci19855261826252995603
- 71MilnerTECadoretGLessardLSmithAMEMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive.J Neurophysiol199573256825777666163
- 72KraussJKWakhlooAKNobbeFTränkleRMundingerFSeegerWLesion of dentatothalamic pathways in severe post-traumatic tremor.Neurol Res1995174094168622792
- 73ElbleRJSchieberMHThachWT
Jr Activity of muscle spindles, motor cortex and cerebellar nuclei during action tremor.Brain Res198432333033410.1016/0006-8993(84)90308-16241010 - 74MonzéeJDrewTSmithAMEffects of muscimol inactivation of the cerebellar nuclei on precision grip.J Neurophysiol2004911240124910.1152/jn.01124.200214681335
- 75GembaHSasakiKYonedaYHashimotoSMizunoNTremor in the monkey with a cerebellar lesion.Exp Neurol19806917318210.1016/0014-4886(80)90152-16771153
- 76LlinásRMühlethalerMElectrophysiology of guinea-pig cerebellar nuclear cells in the in vitro brain stem-cerebellar preparation.J Physiol19884042412582855348
- 77LamarreYJoffroyAJDumontMDe MontignyCGrouFLundJPCentral mechanisms of tremor in some feline and primate models.Can J Neurol Sci19752227233809126
- 78BattistaAFNakataniSGoldsteinMAnagnosteBEffect of harmaline in monkeys with central nervous system lesions.Exp Neurol19702851352410.1016/0014-4886(70)90189-54990930
- 79VillablancaJRiobóFElectroencephalographic and behavioral effects of harmaline in intact cats and in cats with chronic mesencephalic transection.Psychopharmacologia19701730231310.1007/BF004042354331726
- 80BekarLLibionkaWTianGFAdenosine is crucial for deep brain stimulation-mediated attenuation of tremor.Nat Med200814758010.1038/nm169318157140
- 81DeecherDCTeitlerMSoderlundDMBornmannWGKuehneMEGlickSDMechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.Brain Res199257124224710.1016/0006-8993(92)90661-R1377086
- 82HelsleySFiorellaDRabinRAWinterJCBehavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.Pharmacol Biochem Behav19985941942510.1016/S0091-3057(97)00451-69476990
- 83GrellaBDukatMYoungRInvestigation of hallucinogenic and related β-carbolines.Drug Alcohol Depend1998509910710.1016/S0376-8716(97)00163-49649961
- 84RobertsonHAHarmaline-induced tremor: the benzodiazepine receptor as a site of action.Eur J Pharmacol19806712913210.1016/0014-2999(80)90020-56252023
- 85SugiharaILangEJLlinásRSerotonin modulation of inferior olivary oscillations and synchronicity: a multiple-electrode study in the rat cerebellum.Eur J Neurosci1995752153410.1111/j.1460-9568.1995.tb00657.x7620604
- 86DuWAloyoVJHarveyJAHarmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain.Brain Res1997770262910.1016/S0006-8993(97)00606-99372198
- 87MousahHJacqminPLesneMInteraction of carbolines and some GABA receptor ligands with the GABA and the benzodiazepine receptors.J Pharmacol1986176866913031382
- 88SchweriMCainMCookJPaulSSkolnickPBlockade of 3-carbomethoxy-β-carboline induced seizures by diazepam and the benzodiazepine antagonists, Ro 15-1788 and CGS8216.Pharmacol Biochem Behav19821745746010.1016/0091-3057(82)90304-56815667
- 89FrostholmAEvansJECummingsSLRotterAHarmaline-induced changes in gamma aminobutyric acidA receptor subunit mRNA expression in murine olivocerebellar nuclei.Brain Res Mol Brain Res20008520020810.1016/S0169-328X(00)00259-X11146122
- 90IshidaHSasaMTakaoriSIshidaHEffects of harmaline on membrane excitability and ATPase activity of the crayfish giant axon.Jpn J Pharmacol19813180180710.1254/jjp.31.8016118455
- 91SplettstoesserFBonnetUWiemannMBingmannDBüsselbergDModulation of voltage-gated channel currents by harmaline and harmane.Br J Pharmacol2005144525810.1038/sj.bjp.070602415644868
- 92SmartLCompetitive inhibition of sodium-dependent high affinity choline uptake by harmala alkaloids.Eur J Pharmacol19817526526910.1016/0014-2999(81)90553-77318912
- 93McCormickSJTunnicliffGInhibitors of synaptosomal gamma-hydroxybutyrate transport.Pharmacology19985712413110.1159/0000282339691232
- 94SchwarzMJHoughtonPJRoseSJennerPLeesADActivities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.Pharmacol Biochem Behav20037562763310.1016/S0091-3057(03)00129-112895680
- 95RobertsEWongESvennebyGDegenerPSodium-dependent binding of GABA to mouse brain particles.Brain Res197815261461910.1016/0006-8993(78)91119-880248
- 96ReidMSHsuK
Jr SouzaKHBroderickPABergerSPNeuropharmacological characterization of local ibogaine effects on dopamine release.J Neural Transm199610396798510.1007/BF012917879013390 - 97PimpinellaGPalmeryMInteraction of β-carbolines with central dopaminergic transmission in mice: structure-activity relationships.Neurosci Lett199518912112410.1016/0304-3940(95)11469-D7609916
- 98CummingPVincentSRInhibition of histamine-N-methyltransferase (HNMT) by fragments of 9-amino-1,2,3,4-tetrahydroacridine (tacrine) and by β-carbolines.Biochem Pharmacol19924498999210.1016/0006-2952(92)90133-41530666
- 99AiraksinenMMLecklinASaanoVTuomistoLGyntherJTremorigenic effect and inhibition of tryptamine and serotonin receptor binding by β-carbolines.Pharmacol Toxicol1987605810.1111/j.1600-0773.1987.tb01711.x3562389
- 100MirallesAEstebanSSastre-CollAMorantaDAsensioVJGarcia-SevillaJAHigh--affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.Eur J Pharmacol200551823424210.1016/j.ejphar.2005.06.02316061219
- 101WiklundLSjölundBBjörklundAMorphological and functional studies on the serotoninergic innervation of the inferior olive.J Physiol (Paris)1981771831866169826
- 102SjölundBBjörklundAWiklundLThe indolaminergic innervation of the inferior olive. 2. Relation to harmaline induced tremor.Brain Res1977131233710.1016/0006-8993(77)90026-9884545
- 103CostallBKellyDMNaylorRJThe importance of 5-hydroxytryptamine for the induction of harmine tremor and its antagonism by dopaminergic agonists assessed by lesions of the midbrain raphe nuclei.Eur J Pharmacol19763510911910.1016/0014-2999(76)90305-81253813
- 104WelshJPChangBMenakerMEAicherSARemoval of the inferior olive abolishes myoclonic seizures associated with a loss of olivary serotonin.Neuroscience19988287989710.1016/S0306-4522(97)00297-29483543
- 105MehtaHSaravananKSMohanakumarKPSerotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice.Behav Brain Res2003145313610.1016/S0166-4328(03)00094-914529803
- 106ArshaduddinMKadasahSAl DeebSAl MoutaeryKTariqMExacerbation of harmaline-induced tremor by imipramine.Pharmacol Biochem Behav20058191410.1016/j.pbb.2005.01.01415894058
- 107ArshaduddinMAl KadasahSBiaryNAl DeebSAl MoutaeryKTariqMCitalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats.Behav Brain Res2004153152010.1016/j.bbr.2003.10.03515219702
- 108YamazakiMIkedaYIshikawaMInagakiCTanakaCInhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor.Nippon Yakurigaku Zasshi19767236336910.1254/fpj.72.363986992
- 109YamazakiMTanakaCTakaoriSSignificance of central noradrenergic system on harmaline induced tremor.Pharmacol Biochem Behav19791042142710.1016/0091-3057(79)90207-7450952
- 110KolasiewiczWKuterKNowakPPastuszkaAOssowskaKLesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.Cerebellum20111026728010.1007/s12311-011-0250-921279489
- 111CoxBPotkonjakDAn investigation of the tremorgenic actions of harmine in the rat.Eur J Pharmacol197116394510.1016/0014-2999(71)90054-94945584
- 112KulkarniSKKaulPNModification by levo-propranolol of tremors induced by harmine in mice.Experientia1979351627162810.1007/BF01953232520477
- 113PaulVInvolvement of β2-adrenoceptor blockade and 5-hydroxytryptamine mechanism in inhibition of harmaline-induced tremors in rats.Eur J Pharmacol198612211111510.1016/0014-2999(86)90165-22869961
- 114NiespodzianyIKlitgaardHMargineanuDEffects of brivaracetam (UCB 34714) on harmaline-induced electrophysiological changes in rat inferior olivary neurons.Soc Neurosci Abst20059711
- 115WoodPLRichardJWPilapilCNairNPAntagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellum.Neuropharmacology1982211235123810.1016/0028-3908(82)90126-56130488
- 116KollerWCIneffectiveness of phenoxybenzamine in essential tremor.J Neurol Neurosurg Psychiatry19864922210.1136/jnnp.49.2.222-a3950649
- 117EblenFLöschmannPAWüllnerUTurskiLKlockgetherTEffects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.Eur J Pharmacol199629991610.1016/0014-2999(95)00795-48901001
- 118PatersonNEMalekianiSAForemanMMOlivierBHananiaTPharmacological characterization of harmaline-induced tremor activity in mice.Eur J Pharmacol2009616738010.1016/j.ejphar.2009.05.03119497322
- 119DuWHarveyJAHarmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit.Brain Res199774518318810.1016/S0006-8993(96)01148-19037408
- 120IseriPKKarsonAGulluKMThe effect of memantine in harmaline-induced tremor and neurodegeneration.Neuropharmacology20116171572310.1016/j.neuropharm.2011.05.01521640732
- 121HandforthABordelonYFruchtSJQuesadaAA pilot efficacy and tolerability trial of memantine for essential tremor.Clin Neuropharmacol20103322322610.1097/WNF.0b013e3181ebd10920838216
- 122MignaniSBohmeGABirrauxG9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist.Bioorg Med Chem2002101627163710.1016/S0968-0896(01)00431-X11886824
- 123KolasiewiczWKuterKWardasJOssowskaKRole of the metabotropic glutamate receptor subtype 1 in the harmaline-induced tremor in rats.J Neural Transm20091161059106310.1007/s00702-009-0254-519551466
- 124ShinozakiHHirateKIshidaMFurther studies on quantification of drug-induced tremor in mice: effects of antitremorgenic agents on tremor frequency.Exp Neurol19858830331510.1016/0014-4886(85)90193-13987859
- 125TariqMArshaduddinMBiaryNAl MoutaeryKAl DeebSBaclofen attenuates harmaline induced tremors in rats.Neurosci Lett2001312798210.1016/S0304-3940(01)02166-811595339
- 126MeertTFPharmacological evaluation of alcohol withdrawal-induced inhibition of exploratory behaviour and supersensitivity to harmine-induced tremor.Alcohol Alcohol199429911027911667
- 127RappaportMSGentryRTSchneiderDRDoleVPEthanol effects on harmaline--induced tremor and increase of cerebellar cyclic GMP.Life Sci198434495610.1016/0024-3205(84)90329-16319933
- 128RogersJMadambaSGStauntonDASigginsGREthanol increases single unit activity in the inferior olivary nucleus.Brain Res 1986 22385253262
- 129GarbourgYWelshJPSystemic ethanol induces inferior olive synchrony and oscillation in vivo.Soc Neurosci Abst200074316
- 130De RyckMMatagneAKendaBMichelPKlitgaardHContrasting effects of UCB 34714 and drugs for essential tremor on harmaline-induced elicited versus spontaneous tremor and sedation in rats.Mov Disord200419S443
- 131HandforthAMartinFCKangGAVanekZZonisamide for essential tremor: an evaluator-blinded study.Mov Disord20092443744010.1002/mds.2241819117357
- 132StöhrTLekieffreDFreitagJLacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats.Eur J Pharmacol200858911411610.1016/j.ejphar.2008.06.03818585381
- 133GironellAPagonabarragaJPascual-SedanoBKulisevskyJLacosamide, another therapeutic failure in essential tremor: an open-label trial.Mov Disord20112618318410.1002/mds.2329620925072
- 134ElbleRJBiondiDMAscherSWiegandFHulihanJCarisbamate in essential tremor: brief report of a proof of concept study.Mov Disord20102563463810.1002/mds.2287220201005
- 135MartinFCHandforthACarbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor.Mov Disord2006211641164910.1002/mds.2094016773639
- 136ZappalàAParentiRLa DeliaFCicirataVCicirataFExpression of connexin57 in mouse development and in harmaline-tremor model.Neuroscience201017111110.1016/j.neuroscience.2010.09.01020849935
- 137SintonCMKrosserBIWaltonKDLlinásRRThe effectiveness of different isomers of octanol as blockers of harmaline-induced tremor.Pflugers Arch1989414313610.1007/BF005856232542888
- 138HandforthAHomanicsGECoveyDFT-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.Neuropharmacology20105938038710.1016/j.neuropharm.2010.05.01220547167
- 139QuesadaABuiPHHomanicsGEHankinsonOHandforthAComparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor.Eur J Pharmacol2011659303610.1016/j.ejphar.2011.01.004
- 140BuiPHQuesadaAHandforthAHankinsonOThe mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil.Drug Metab Dispos2008361291129910.1124/dmd.107.02011518411403
- 141Al-DeebSAl-MoutaeryKArshaduddinMBiaryNTariqMEffect of acute caffeine on severity of harmaline induced tremor in rats.Neurosci Lett200232521621810.1016/S0304-3940(02)00042-312044659
- 142BiaryNArshaduddinMAl DeebSAl MoutaeryKTariqMEffect of lidocaine on harmaline-induced tremors in the rat.Pharmacol Biochem Behav20006511712110.1016/S0091-3057(99)00175-610638644
- 143BertiFFanoMFolcoGCLongiaveDOminiCInhibition of harmaline induced tremors by 16 (S)-16-methyl PGE2 in different mammalian species: a correlation with central cyclic nucleotides and prostaglandins.Prostaglandins19781586787410.1016/0090-6980(78)90153-3704910
- 144ShutoHKataokaYKanayaAMatsunagaKSueyasuMOishiREnhancement of serotonergic neural activity contributes to cyclosporine-induced tremors in mice.Eur J Pharmacol1998341333710.1016/S0014-2999(97)01441-69489853
- 145ZoethoutRWIannoneRBloemBRThe effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol.J Psychopharmacol20122629230210.1177/026988111139868521335358
- 146ScarmeasNLouisEDMediterranean diet and essential tremor. A case-control study.Neuroepidemiology20072917017710.1159/00011157918043001
- 147LouisEDFaustPLVonsattelJPNeuropathological changes in essential tremor: 33 cases compared with 21 controls.Brain20071303297330710.1093/brain/awm26618025031
- 148KronenbuergerMGerwigMBrolBBlockFTimmannDEyeblink conditioning is impaired in subjects with essential tremor.Brain20071301538155110.1093/brain/awm08117468116
- 149HallettMDubinskyRMGlucose metabolism in the brain of patients with essential tremor.J Neurol Sci1993114454810.1016/0022-510X(93)90047-38433096
- 150WillsAJJenkinsIHThompsonPDFindleyLJBrooksDJRed nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study.Ann Neurol19943663664210.1002/ana.4103604137944296
- 151BoeckerHWillsAJCeballos-BaumannAThe effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study.Ann Neurol19963965065810.1002/ana.4103905158619551
- 152ShillHABusharaKOMariZReichMHallettMOpen-label dose-escalation study of oral 1-octanol in patients with essential tremor.Neurology2004622320232210.1212/WNL.62.12.232015210907
- 153NahabFBWittevrongelLIppolitoDAn open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor.Neurotherapeutics2011875376210.1007/s13311-011-0045-121594724
- 154HandforthAMartinFCPilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.Mov Disord2004191215122110.1002/mds.2014715390011
- 155FruchtSJHoughtonWCBordelonYGreenePELouisEDA single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor.Neurology2005651967196910.1212/01.wnl.0000188670.38576.bd16382538
